Enterococci, such as Enterococcus faecalis, are a significant cause of hospital-acquired 40 bacteremia and mortality among the elderly and patients with comorbid conditions in the 41 healthcare setting. In this study, the novel discovery is made that cardiac microlesions form during 42 severe bacteremic E. faecalis infection in mice. The cardiac microlesions were identical in 43 appearance to those previously observed to form by Streptococcus pneumoniae during invasive 44 pneumococcal disease (IPD) in mice, non-human primates, and humans. However, E. faecalis 45 does not encode the virulence determinants implicated in pneumococcal microlesion formation, 46 suggesting that formation is through an alternative pathway. In previous work, we showed that E. 47 faecalis DsbA is required for the post-translational disulfide bond formation and stability of EntV, 48 a secreted E. faecalis bacteriocin. Here, the role of DsbA in E. faecalis pathogenicity was 49 explored. DsbA was discovered to be required for E. faecalis virulence in a C. elegans model and, 50 importantly, was necessary for efficient cardiac microlesion formation. By investigating the cardiac 51 host response, it was discovered that E. faecalis promotes cardiomyocyte necroptotic cell death 52 at sites of microlesion formation. Additionally, by examining the cytokines induced by exposure 53 of E. faecalis to cardiomyocytes, it was revealed that loss of DsbA caused a pro-inflammatory 54 response unlike the wild type strain, which suppressed the immune response. In conclusion, we 55 establish that E. faecalis is capable of forming cardiac microlesions and identify features of both 56 the bacterial and host responses that are mechanistically involved. 57 58 59 60 61 Significance Statement 62 63 E. faecalis is a bacterium capable of causing serious disease in humans, including endocarditis, 64
Introduction 73 74
Enterococcus faecalis is a Gram-positive bacterium that normally co-exists with the host as a 75 harmless commensal. However, it is capable of causing a variety of infections such as infective 76 endocarditis (IE), urinary tract infection (UTI), bacteremia, peritonitis, prosthetic joint infection, and 77 endophthalmitis. These infections can become life-threatening if left untreated (1, 2) . Furthermore, 78
immunocompromised individuals and those with underlying disease are at an increased risk (3-79 5) . Enterococcal infections are increasingly characterized by the presence of antimicrobial 80 resistance such as vancomycin resistant enterococci (VRE). Due to their intrinsic ability to survive 81 various environmental habitats (3), the bacterium poses a significant threat in hospitals and long-82 term care facilities where VRE has increased access to immunocompromised patients through 83 infection of open wounds, or through the use of contaminated medical devices (6, 7). As such, 84 enterococci are a common nosocomial pathogen, having been observed to be the etiological 85 agent responsible for 14% of all hospital-acquired infections (HAIs) in the US between 2011-2014 86 (8) . Therefore, it is no surprise that enterococci are a significant cause of hospital-acquired 87 bacteremia and mortality among the elderly and patients with comorbid conditions in the 88 healthcare setting (9) (10) (11) (12) . 89 90 Enterococcal infections often lead to other clinical manifestations. A common complication 91 associated with bacteremia is endocarditis, an infection that has a 1-year mortality rate of 92 approximately 29% despite antibiotic therapy (11) . Enterococci are the third most common cause 93 of endocarditis in North America (5) and, in patients with this infection, heart failure has been 94 observed to occur with increased frequency (13) (14) (15) (16) (17) (18) (19) . Infective endocarditis involves the formation 95 of biofilms on heart valves and inner chambers that develop into complex masses called 96 vegetations (2). Thus, heart infections associated with E. faecalis have traditionally been 97 characterized as occurring on the surfaces of the heart, rather than in the deeper myocardial 98 tissue, which would require active invasion by the bacterium. 99 100 Interestingly, another important Gram-positive pathogen, Streptococcus pneumoniae, was 101 recently shown to invade the heart tissue and form cardiac microlesions during invasive 102 pneumococcal disease (IPD) (20) . The microlesions occurred in mice, non-human primates, and 103 humans with IPD and were shown to be associated with altered cardiac electrophysiology, heart 104 failure in mice, and scar formation during convalescence (20) . Scar formation following 105 microlesion development is thought to predispose individuals to major adverse cardiac events 106 (MACE) (21). Moreover, cardiac microlesions were shown to form following vascular endothelial 107 cell invasion into the myocardial tissue, followed by subsequent interactions between 108 pneumococcal Choline binding protein A (CbpA) and pneumococcal teichoic acid associated 109 phosphorylcholine (ChoP) with host laminin receptor (LR) and platelet activating factor receptor 110 (PAFr), respectively. Furthermore, cardiomyocyte death is mediated by exposure to the 111 pneumococcal secreted cholesterol-dependent pore forming toxin, pneumolysin (20, 21) , and 112 hydrogen peroxide (22, 23) . As such, cardiac microlesions have been proposed to be a 113 contributory factor to the onset of MACE observed in older patients with IPD, or in convalescent 114 patients previously hospitalized with IPD (20, 24, 25) . Importantly, invasive infection is now 115 appreciated as a risk factor for myocardial infarction, and the risk appears to be more pronounced 116 depending on the severity of the infection (26, 27) . Since the original observation of pneumococcal 117 microlesions in 2014, no other organism has been observed to cause such pathology. 118
119
In this report, we show that cardiac microlesions also form during invasive E. faecalis infection. 120
The observed cardiac microlesions are identical in appearance and size to S. pneumoniae 121 mediated cardiac microlesions, are diffuse across the myocardium, and are characterized by an absence of immune cell infiltration. Furthermore, we identify a mode of cardiomyocyte cell death, 123
and an enterococcal determinant required for microlesion formation. Our findings suggest a 124 previously unrecognized pathological aspect of enterococcal infection that may be a contributing 125 factor to the increased rate of heart failure and mortality observed in patients with endocarditis 126 (13) (14) (15) (16) (17) (18) (19) . Importantly, because E. faecalis lacks homologs of the virulence determinants previously 127 implicated in pneumococcal microlesion formation, the mechanism of microlesion formation for E. 128 faecalis is likely through an alternative pathway. 129 130 131 Cardiac microlesions form during severe bacteremic E. faecalis infection. In previous work, 134
we implicated a previously uncharacterized E. faecalis thioredoxin known as DsbA (disulfide bond 135 forming protein A) as a requirement for the stability of EntV, a secreted bacteriocin that we 136 determined inhibits hyphal morphogenesis of the human fungal pathogen Candida albicans (28, 137 29) . To test if these proteins had any effects on the fitness and pathogenicity of E. faecalis, we 138
infected Caenorhabditis elegans with dsbA and entV E. faecalis mutants and measured 139 survival. As shown in Figure 1A , loss of dsbA significantly attenuated mortality in infected 140 nematodes. Note that the dsbA mutant did not manifest different growth kinetics when grown in 141 culture medium compared to wild type, ruling out a general growth defect ( Figure S1 ). Infection 142 with the complement, dsbA::dsbA, partially rescued the dsbA phenotype. The partial 143 complementation was attributed to the DsbA protein being produced at lower levels in the 144 complemented strain ( Figure 1B ). No significant difference in nematode survival was observed 145 following infection with either the entV mutant or its complement ( Fig. 1A) . Considering that EntV 146 is the only known substrate of E. faecalis DsbA, the results suggest that DsbA has additional 147 targets that affect pathogenicity. 148
149
Based on these results, we wanted to know if loss of DsbA also affected virulence in a vertebrate 150 animal model of E. faecalis infection. Therefore, the mutants were tested in a mouse model in 151 which animals were injected intra-peritoneally with E. faecalis resulting in generalized bacteremia 152 leading to mortality. Significant survival differences between the mice infected with the different 153 strains were not observed. However, various organs were collected in order to determine if E.
( Fig. 2 A, B ). The microlesions appeared to form within roughly the same time frame (~24 h.p.i.) 157 as cardiac microlesions that have previously been reported to occur during invasive infection with 158 S. pneumoniae, the only other pathogen known to cause cardiac microlesions to date (20) . microlesions found on hematoxylin and eosin stained paraffin embedded cardiac sections were 173 quantified following infection with ΔdsbA. From these experiments, a significant attenuation in 174 microlesion formation during infection with dsbA was observed relative to wild type, while no 175 significant difference was observed in mice infected with the dsbA complement ( Fig. 2E) . 176 Furthermore, when the sizes of the cardiac microlesions were compared, the wild-type lesions 177 were significantly larger than those found in the ΔdsbA infected mice ( Fig. 2F ). Importantly, the 178 size of the microlesions appeared to correlate with level of dsbA expression observed in Western 179 blots of E. faecalis whole cell lysates ( Fig. 1B) , with the dsbA::dsbA strain manifesting an in-180 between phenotype to that of the dsbA and wild-type strains, consistent with partial complementation. In conclusion, these data demonstrate that cardiac microlesion formation 182 occurs during systematic infection with E. faecalis and is dependent on DsbA. Thus, for the first 183 time, loss of DsbA in E. faecalis is shown to affect pathogenicity in animal models of infection, 184
both invertebrate (C. elegans) and vertebrate (mice). 185 186 Necroptosis contributes to cardiomyocyte cell death within microlesions. In previous 187 studies of pneumococcal cardiac microlesion formation, apoptosis was found to be associated 188 with microlesion formation in mice (22) . A subsequent study determined that cardiomyocyte cell 189 death occurs following exposure to pneumolysin (ply) and pneumococcal derived hydrogen 190 peroxide (spxB) (23). Based on these observations and the fact that E. faecalis lacks ply and spxB 191 homologs, we sought to determine whether E. faecalis could promote cell death of 192 cardiomyocytes and identify the mechanism. First, HL-1 cardiomyocytes were infected with E. 193 faecalis and subsequently lactate dehydrogenase (LDH) release into the cell culture supernatant 194 was measured to assess cell death. From these experiments, it was concluded that E. faecalis 195 induces cell death of cardiomyocytes. Furthermore, infection with a dsbA mutant resulted in a 196 significant decrease in cardiomyocyte cell death ( Fig. 3B ), suggesting DsbA is required to 197 modulate this process. Since cardiomyocyte cell death was observed following exposure to E. 198 faecalis, we wanted to identify the mechanism. To test this question, an annexin V apoptosis and 199 necrosis assay was performed to determine if E. faecalis promotes apoptosis or necrosis during 200 cardiomyocyte infection. The signals for both apoptosis and necrosis increased concomitantly 201 with time ( Figure S2 ), and this read-out means that cell death is occurring by an apoptosis-202 independent mechanism (see Materials and Methods). One apoptosis-independent cell death 203 pathway is necroptosis, and this mechanism of cell death is consistent with data published by 204 investigators studying S. pnuemoniae microlesions, which showed that markers of necroptosis 205 could be detected within the myocardium of acutely ill mice (20) and non-human primates (21). 206 Importantly, necroptosis is considered a key cell death pathway in cardiomyocytes during 207 ischemia-reperfusion injury and acute coronary syndrome (31) (32) (33) . To test the hypothesis that 208 cardiomyocytes undergo necroptosis following exposure to E. faecalis, we infected HL-1 209 cardiomyocytes with this bacterium in the presence of various inhibitors of necroptosis and 210 observed a significant suppression of cell death (Fig. 3C ). Additionally, staining for markers of 211 necroptosis (34), such as mixed lineage kinase domain-like pseudokinase (MLKL) and 212 phosphorylated MLKL, on cardiac tissue sections obtained from infected mice showed 213 concentrated signals within the microlesions ( Fig 3D) . Despite the ability of E. faecalis to promote 214 death of the cardiomyocytes following exposure, antibiotic protection assays indicated that the 215 bacteria were unable to invade cardiomyocytes relative to endothelial cells ( Fig. 3A) . No difference 216 was observed in either the ability to promote necroptosis or cell invasion following exposure to 217 dsbA relative to wild-type ( Figure S3 ). Taken together, these results suggest that during 218 bacteremia, E. faecalis is able to translocate across the vascular endothelium in order to enter 219 the myocardial tissue. Once there, E. faecalis is unable to invade cardiomyocytes, but can form 220 microcolonies that promote necroptotic cell death. 221
Cardiomyocyte inflammatory cytokine response is suppressed following exposure to E. 222 faecalis. Cardiac microlesions are characterized by bacteria filled vacuoles that are largely devoid 223 of immune cell infiltrate (20, 30) . Therefore, this pathology was distinguished from myocardial 224 abscesses, commonly caused by Staphylococcus aureus, which are suppurative infections 225 characterized by a robust immune cell infiltrate within the cardiac tissue (20, 35) . Previous efforts 226 to explain the lack of an immune response to pneumococcal microlesions have yielded interesting 227 insights. For example, S. pneumoniae within microlesions are thought to subvert the host 228 response through a biofilm-mediated mechanism involving the pneumolysin mediated killing of 229 resident macrophages, thus creating a more permissive environment for pneumococcal growth previous work, it was shown that E. faecalis can survive within mouse peritoneal macrophages 232 for extended periods of time enabling the bacteria to replicate and spread (36). In more recent 233 work, E. faecalis was shown to activate Phosphatidylinositol 3-Kinase signaling that inhibits 234 apoptosis (37). E. faecalis can also resist phagosome acidification and autophagy within 235 macrophages (38) . Because E. faecalis does not encode a pneumolysin homolog, nor does it 236 secrete toxins known to kill macrophages or other immune cells, we wanted to examine the 237 immune response to E. faecalis within the heart by measuring various inflammatory cytokines and 238 chemokines. Experiments assessing cardiomyocyte inflammatory chemokine and cytokine levels 239 showed that wild-type E. faecalis promotes an immune quiescent response, while loss of dsbA 240 leads to a more inflammatory immune response ( Fig. 4A ). Interestingly, EGF, M1P-1a, GM-CSF, 241 IL-6, G-CSF, and INFr were significantly upregulated during infection with dsbA relative to the 242 wild-type infected cardiomyocytes. Thus, these results implicate the contribution of specific host 243 signaling pathways involved in pathogen clearance that are normally suppressed in the presence 244
of DsbA during infection, as modeled in Figure 4B . Collectively, these data suggest that E. faecalis 245 inhibits a vigorous cardiomyocyte immune response in a manner similar to that of S. pneumoniae 246 despite lacking the components that S. pneumoniae uses during immune subversion. Future 247 studies will be focused on understanding the cardiomyocyte immune response during 248 enterococcal infection, and how DsbA contributes. 249 These include EfbA, which binds fibronectin (39), ACE, which binds laminin receptor (40), and 261
Ebp pili that bind fibrinogen (41). 262 263 Interestingly, we did discover one factor, DsbA, that contributes to microlesion formation and 264 inhibition of the cardiomyocyte inflammatory immune response, as modeled in Figure 4B . Dsb 265 proteins work to catalyze disulfide bond formation in proteins and have been best studied in Gram-266 negative bacteria where they catalyze the oxidative folding of proteins in the periplasm (42, 43) . 267
In Gram-positive bacteria, oxidative protein folding of proteins targeted for the cell envelope or 268 secretion is thought to occur in the exoplasm, the area immediately outside of the cytoplasmic 269 membrane but before the peptidoglycan layer (42) the only one identified (28). However, loss of EntV did not reduce pathogenicity in the worm model 285 ( Figure 1A) , and exposure to EntV, even at very high concentrations, was non-toxic to mammalian 286 cells (29). Thus, we do not favor EntV as being the source of DsbA's effects. A primary future 287 direction will be identifying additional substrates of DsbA and determining which contribute to 288 microlesion formation. Not only will this provide insight into the developmental requirements for 289 this cardiac pathology that promotes cardiomyocyte necroptosis, it will also impact understanding 290 of E. faecalis pathogenesis and the biology of disulfide bond forming proteins in bacteria. 291 292 Pneumococcal ChoP interactions with host PAFr were determined to be a prerequisite for 293 vascular endothelial cell invasion during IPD. In S. pneumoniae, the main wall teichoic acid chain 294 repeat is composed of 2-acetamido-4-amino-2,4,6-trideoxygalactose, glucose, ribitol-phosphate 295 and two GalNAc moieties, each decorated with phosphorylcholine. This cell wall teichoic acid 296 structure is considered rare and is thought to be exclusive to S. pneumoniae (47, 48) . In light of 297 our observations of E. faecalis invasion of vascular endothelial cells despite an absence of this 298 wall teichoic acid structure, it is possible that another host receptor is required for endothelial cell 299 invasion. Interestingly, recent studies focused on bacterial cell wall entry and signaling in eukaryotic cells have identified a PAFr-independent mechanism of tissue invasion that is actin-301 dependent and engenders Rac1, Cdc42, and phosphatidylinositol 3-kinase (PI3K) signaling 302 leading to cell wall internalization via a macropinoctytosis-like pathway (49). Whether such a 303 pathway contributes to microlesion formation is unknown. In the future, it will be of interest to study 304 the mechanisms of tissue invasion and the host signaling pathways involved. 305
306
Cardiac microlesion formation is becoming increasingly appreciated as a risk factor during acute 307 infection (25), and this study establishes that E. faecalis is another etiological agent capable of 308 causing this pathology in a vertebrate animal model. There is an increased occurrence of heart 309 failure observed in patients with endocarditis (13-19), and we hypothesize that invasive infection 310 resulting in microlesions additionally occurs and is a contributing factor. It will be important to 311
investigate whether E. faecalis microlesions occur in humans and whether they contribute to 312 adverse cardiac events. As nosocomial derived enterococcal infections are increasingly 313 problematic among the elderly and immunocompromised patients (8-12), the development of 314 successful treatments will require identifying all disease manifestations as well as the bacterial 315 and the host factors involved. E. faecalis strains were tested in C. elegans for survival as previously described (50). Briefly, C. 323 elegans strain N2 was maintained and propagated on Escherichia coli strain OP50 with standard 324
techniques. 30 C. elegans L4 nematodes were transferred from a lawn of Escherichia coli OP50 325 to a lawn of E. faecalis to be tested, incubated at 25°C, and examined at ≈24-hr intervals with a 326 dissecting microscope for viability. Worms were considered dead when they did not respond to 327 touch with a platinum wire pick. The data is representative of 3 independent experiments. 328
Nematode survival was plotted with the log-rank (Mantel-Cox) method using Prism 7 statistical 329 software (GraphPad). 330 331
Bacterial strains and growth analysis 332
All E. faecalis strains used in this project were used in previously published studies (28) and are 333 listed in Table S1 . In a 96 well plate, overnight cultures (grown ~15 hours) of OG1RF strains were 334 diluted to an OD600nm of 0.05 in brain heart infusion (BHI) agar medium (Difco) in a volume of 335 200µl / well in a 96-well plate. The 96-well plate containing the diluted cultures were then placed 336 in a prewarmed 37ºC BioTek Cytation 5 plate reader, and OD600nm measurements were taken 337 every 10 minutes for 15 hours. Prior to measurement, the plate was gently agitated for 5 seconds. 338 339
Mouse peritonitis and cardiac microlesion model 340
The mouse peritonitis model was performed as described previously (51). The method for 341 identifying and evaluating cardiac microlesion formation was conducted as described previously 342 
Necroptosis inhibition assay 355
HL-1 cardiomyocytes were seeded in 24-well plates at a concentration of 5x10 5 cells/ml. 24 hours 356 later, the cells were washed three times with Dulbecco's (1X) PBS, followed by pretreatment with 357 antibiotic free Claycomb medium supplemented with 10 µM of Necrostatin-1 (Sigma Aldrich), 358 GSK'872 (RD Systems), and Necrosulfonamaide (Millipore-Sigma) for 1 hour, followed by 359 infection at an MOI of 10 for 4 hours, following which the supernatant was collected, and 360 cytotoxicity in each well accessed using the CytoTox-ONE™ Homogeneous Membrane Integrity 361 Assay Kit (Promega). Each experiment was conducted in triplicate, on 3 separate occasions, and 362 averaged values between groups compared using using Student's two-tailed t-test. 363 364
Annexin V apoptosis and necrosis assay. 365
The annexin V apoptosis and necrosis assay was conducted using RealTime-Glo™ Annexin V 366
Apoptosis and Necrosis Assay Kit (Promega). The kit contains near-equimolar ratios of two 367 annexin V fusion proteins (Annexin V-LgBiT and Annexin V-SmBit) containing complementary 368 subunits of NanoBiT® Luciferase that, when combined following exposure to phosphatidyl serine, results in an emission of a luminescent signal. The kit also contains a cell-impermeant 370 profluorescent DNA dye, which detects necrosis. Briefly, HL-1 cardiomyocytes (Sigma-Aldrich) 371
were seeded in a 96 well plate. 24 hours later, the cells were infected with E. faecalis at an MOI 372 = 50, in the presence of kit reagents. Luminescent and fluorescent readings were obtained every 373 30 minutes for up to 6 hours. 374 375 Invasion assay 376 SVEC4-10 Endothelial Cells (ATCC) were seeded in 24 well plates at a cell density of 1.5x10 5 377 cells/ml. After 24 hours, the cells were washed three times with PBS, and infected with E. faecalis 378 at a MOI of 10 for 4 hours in antibiotic free Claycomb medium. After the incubation, the cells were 379 washed with Dulbecco's (1X) PBS three times and treated with trypsin, diluted in PBS, and plated 380 on BHI agar plates for attachment quantification. To measure intracellular numbers of E. faecalis, 381 cells that were washed three times with Dulbecco's (1X) PBS 4 h.p.i., then treated with Dulbecco's 382
Modified Eagle's Medium (ATCC) supplemented with 15 μg/ml vancomycin and 150 μg/ml 383 gentamicin. 24 hours later, the wells were washed three times with Dulbecco's (1X) PBS, lysed 384 using 0.1% Triton-X-100, and diluted and plated on BHI agar plates for intracellular quantification. 385
The ratio of invasion to attachment for a given enterococcal strain was used to calculate the 386 percent of invasion. The experiments were conducted on 3 independent occasions and were 387 performed using triplicate wells for each strain. Attachment and invasion values were averaged 388 from each experiment, and statistically analyzed using Student's two-tailed t-test. 389 (1X) PBS, and infected with E. faecalis at an MOI of 10 for 4 hours in antibiotic free Claycomb 395 medium. Supernatants were collected and centrifuged for 5 minutes at 10,000 G. Supernatant 396 was collected, and cytotoxicity assayed using CytoTox-ONE™ Homogeneous Membrane 397
Integrity Assay Kit (Promega). In addition to measuring cytotoxicity in HL-1 cardiomyocytes 398 infected with E. faecalis 4 h.p.i, inflammatory chemokines and cytokines were analyzed using a 399
Mouse Cytokine ELISA Plate Array III Colorimetric Assay (Signosis). The data represent an 400 average of at least 3 independent experiments for each isogenic mutant tested and were analyzed 401 using Student's two-tailed t-test. 402 403
Immunofluorescence microscopy 404
Immunofluorescence microcopy was conducted as described previously (20). Briefly, paraffin 405 embedded sections were treated with 1:100 rabbit Anti-mouse MLKL (phospho S345) antibody 406 [EPR9515(2)] in order to detect phosphorylated MLKL (Abcam), and 1:100 rat anti-mouse MLKL 407 antibody (Millipore-Sigma) for MLKL detection followed by treatment with 1:1000 chicken anti-408 rabbit IgG (H+L) cross-adsorbed secondary Alexa Fluor 594 antibody (ThermoFisher), and 1:1000 409 goat anti-rat IgG (H+L) Secondary FITC Antibody (ThermoFisher) respectively. A rabbit anti-410
Enterococcus faecalis antibody (Abcam) was used at a concentration of 1:1000 to detect E. 411 faecalis within cardiac microlesions followed by treatment with 1:1000 goat anti-rabbit IgG (H&L), 412 F(ab)'2 Fragment-affinity purified fluorescein (FITC) conjugate antibody (Invitrogen). All stained 413 sections were counterstained with 1:1000 DAPI (ThermoFisher) and mounted with Hardset™ 414 Antifade Mounting Medium. Visualization of fluorescence was obtained using standard excitation 415 and emission wavelengths for Alexa 594, FITC, and DAPI on an Olympus FV3000RS high-speed 416 high-sensitivity inverted laser scanning confocal microscope. 417
His-tagged recombinant DsbA was overexpressed in Rosetta-2(DE3) E. coli (Sigma-Aldrich) and 420 isolated by affinity purification via HisPur Nickel-NTA Resin (ThermoFisher) packed columns 421 followed by further purification and buffer exchange using Fast Protein Liquid Chromatography 422 (FPLC) to obtain highly pure samples of recombinant DsbA. The recovered recombinant protein 423 was then shipped to Cocalico Biologicals (Reamstown, PA) for generation of anti-DsbA antisera 424 through the immunization of rabbits. Throughout the immunization schedule, regular test bleeds 425 were performed and tested by Western blot using E. faecalis whole cell lysates and recombinant 426
DsbA in order to ensure the specificity of the rabbit anti-DsbA antisera. 427 428 E. faecalis whole cell lysate and Western blot 429 E. faecalis was grown overnight in 5 ml of BHI. The following day (~16 hours later), the media 430 was centrifuged at 6,738 G for 10 min at 4ºC. The pellet was resuspended in 5 ml of BHI, and 431 diluted 10X into fresh BHI media. The culture was subsequently incubated at 37ºC for an 432 additional 3.5 hours to obtain a culture of E. faecalis in exponential growth. The culture was then 433 spun down again at 6,738 G and supernatant removed. The pellet was then resuspended in 1ml 434 of ZAP buffer (10 mM Tris, 200 mM NaCl, pH 7.5) containing 1X protease inhibitor cocktail 435 (Roche) sonicated on ice with a max amplitude of 30%, and alternating on/off cycles consisting of 436 1 minute on, and 10 seconds off for a total of 5 minutes. Following sonication, the sample was 437 centrifuged at 10,000 G for 5 minutes and supernatant collected. The amount of protein in the 438 supernatant was quantified using a DC protein modified Bradford assay (BIORAD), and 10µg of 439 lysate was loaded in each lane of a 12% SDS-PAGE gel. Following electrophoresis and transfer 440 of protein to a PVDF membrane, the membrane was incubated overnight at 4ºC in a 5% milk 441 solution containing a 1:1000 dilution of rabbit anti-DsbA antisera followed by incubation with a 442
Goat anti-rabbit IgG HRP (ThermoFisher) secondary antibody at a dilution of 1:10,000 at room 443 temperature for 30 minutes prior to exposure. 497  498  499  500  501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523 524 525 563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588 A. Supplemental Figure 3 . Loss of dsbA does has no effect on endothelial cell invasion or necroptosis induced cell death of cardiomyocytes. (A) Comparison of WT and dsbA invasion rates into HL-1 cardiomyocytes and SVEC endothelial cells showed no significant difference. The graph represents data from 3 independent experiments analyzed using Student's two-tailed t-test (NS denotes no significance). (B) Comparison of WT and dsbA in HL-1 cardiomyocytes 4 h.p.i. in the presence of inhibitors of necroptosis in-vitro was determined by measuring lactate dehydrogenase. No significant difference was observed between necroptosis inhibitor conditions tested. The data represent an average of 3 independent experiments and were analyzed using Student's two-tailed t-test (* indicate a P < 0.05).
